Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Beckman Coulter Life Sciences snatches up ValitaCell

By Brian Buntz | September 13, 2022

Beckman Coulter/ValitaCellThe lab automation company Beckman Coulter Life Sciences has acquired the Dublin, Ireland–based biotech company ValitaCell.

ValitaCell specializes in developing analytical technologies based on rich cell data to reduce the cost of commercializing new therapeutics.

ValitaCell  boasts that its ValitaTiter product fares better than other industry IgG quantification assays in terms of speed and ease of use. ValitaCell also claims that ValitaTiter has several advantages over techniques such as ELISA and HPLC.

“ValitaCell has a proven record for delivering innovative products and we are excited to build upon our successful partnership with Beckman Coulter Life Sciences,” said Dr. Jerry Clifford, Co-Founder and CEO of ValitaCell, in a news release. “Together with Beckman Coulter Life Sciences, we will advance our shared ambition to accelerate and enable the sustainable manufacture of innovative biological medicines to bring them to market faster.”

ValitaCell has secure intellectual property protections in major international markets.

The company has won a number of awards, including the Irish Pharmaceutical Awards’ Pharma Start-up of the Year in 2017. In late 2016, ValitaCell won €100,000 for winning InterTrade Ireland’s Seedcorn competition.

EU Horizon 2020 recognized ValitaCel as one of the most successful Irish companies, resulting in €2.02 million.

ValitaCell has locations in Dublin and Galway, Ireland. Facilities in those two cities will remain operational following the acquisition.

In August 2022, Beckman Coulter Life Sciences announced a partnership with Flownamics focused on the creation of an automated online technology for bioprocess culture monitoring and control. The alliance will bring together Beckman Coulter’s Vi_CEll BLU cell viability analyzer with Flownamics’ Seg-Flow S3 automated online sampling system.

In July, Beckman Coulter named Cardinal Health veteran Suzanne Foster as president.

In 2020, Indianapolis-based Beckman Coulter Life Sciences agreed to acquire m2p-labs, a German microbioreactor manufacturer.

A year earlier, Beckman Coulter Life Sciences today acquired Cytobank, a privately held, single cell data analysis SaaS company.

Beckman Coulter Life Sciences is part of the Danaher family of companies.

About The Author

Brian Buntz

The pharma and biotech editor of WTWH Media, Brian is a veteran journalist with more than 15 years of experience covering an array of life science topics, including clinical trials, drug discovery and development and medical devices. Before coming to WTWH, he served as content director focused on connected devices at Informa. In addition, Brian covered the medical device sector for 10 years at UBM. At Qmed, he overhauled the brand’s news coverage and helped to grow the site’s traffic volume dramatically. He had previously held managing editor roles on two of the company’s medical device technology publications. Connect with him on LinkedIn or email at bbuntz@wtwhmedia.com.

Tell Us What You Think! Cancel reply

Related Articles Read More >

Moving toward the autonomous lab and what’s possible today
Female worker at pharmaceutical factory operating control panel of the pharmaceutical machine.
How real-time sensors and data-savvy can cut energy waste in pharma
Getinge DPTE-FLEX on a white background.
Getinge launches manual, externally openable port for pharma manufacturing
sherwin-williams-pharma-facility (1)
Sherwin-Williams expands flooring solutions for pharma facilities
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE